References
- Collaborative Normal-Tension Glaucoma Study GroupThe effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucomaAm J Ophthalmol199812644985059780094
- The AGIS InvestigatorsThe Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deteriorationAm J Ophthalmol2000130442944011024415
- DjafariFLeskMRHarasymowyczPJDesjardinsDLachaineJDeterminants of adherence to glaucoma medical therapy in a long-term patient populationJ Glaucoma200918323824319295380
- YoshikawaKKozakiJMaedaHEfficacy and safety of brinzolamide/timolol fixed combination compared with timolol in Japanese patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2014838939924550667
- NagayamaMNakajimaTOnoJSafety and efficacy of a fixed versus unfixed brinzolamide/timolol combination in Japanese patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2014821922824531757
- NakajimaMIwasakiNAdachiMPhase III safety and efficacy study of long-term brinzolamide/timolol fixed combination in Japanese patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol2014814915624403818
- QuarantaLMigliorSFlorianiIPizzolanteTKonstasAGEffects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucomaInvest Ophthalmol Vis Sci200849104226423118502991
- KonstasAGQuarantaLYanDBTwenty-four hour efficacy with the dorzolamide/timolol-fixed combination compared with the brimonidine/timolol-fixed combination in primary open-angle glaucomaEye2012261808721960068
- LanzlIRaberTEfficacy and tolerability of the fixed combination of brinzolamide 1% and timolol 0.5% in daily practiceClin Ophthalmol2011529129821468336
- AugerGARaynorMLongstaffSPatient perspectives when switching from Cosopt® (dorzolamidetimolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapyClin Ophthalmol201262059206223271886
- RossiGCPasinettiGMSandoloFBordinMBianchiPEFrom dorzolamide 2%/timolol 0.5% to brinzolamide 1%/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch studyExpert Opin Pharmacother201112162425243121679090
- LeeBLGutierrezPGordonMThe glaucoma symptom scale. A brief index of glaucoma-specific symptomsArch Ophthalmol199811678618669682698
- ManniGDenisPChewPThe safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertensionJ Glaucoma200918429330019365194
- MundorfTKRauchmanSHWilliamsRDNotivolRBrinzolamide/Timolol Preference Study GroupA patient preference comparison of Azarga™ (brinzolamide/timolol fixed combination) vs Cosopt® (dorzolamide/timolol fixed combination) in patients with open-angle glaucoma or ocular hypertensionClin Ophthalmol20082362362819668763